Browsing: category: Health Care
Some experts believe Novo Nordisk A/S NVO products not only help people lose weight and control diabetes, they can help treat…
Toria Lyttle, a 43-year-old mother from Newtownards, in Northern Ireland, turned to medical marijuana to manage her severe migraines, which…
‘Miracle’ Weight Loss Drug Ozempic To Enter US Price Negotiations Within A Year, Novo Nordisk CEO Says Ahead Of Senate Hearing – Novo Nordisk (NYSE:NVO)
Novo Nordisk’s NVO CEO Lars Fruergaard Jorgensen, has revealed that their diabetes medication and often hailed as a “miracle” weight…
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles – Gilead Sciences (NASDAQ:GILD)
Gilead Sciences Inc. GILD has voluntarily recalled one lot of its COVID-19 treatment, Veklury (remdesivir), for Injection 100 mg/vial, after…
IDEAYA Trades Down As Eye Cancer Treatment Shows Promise – IDEAYA Biosciences (NASDAQ:IDYA), Pfizer (NYSE:PFE)
Ideaya Biosciences Inc. IDYA, a precision medicine oncology company, released interim Phase 2 clinical trial data. The data centers on darovasertib…
Thursday, Moderna Inc MRNA unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling…
Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market – Relay Therapeutics (NASDAQ:RLAY)
Monday, Relay Therapeutics Inc. RLAY shared interim data for RLY-2608 from the ReDiscover study of RLY-2608 alone, in combination with fulvestrant, and…
Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential – Novo Nordisk (NYSE:NVO)
Researchers are now suggesting that a drug for Type 2 diabetes and obesity might actually have anti-aging powers. Harlan Krumholz…
A rare but deadly mosquito-borne virus has prompted nearly a dozen Massachusetts communities to impose nighttime curfews and other restrictions.…
Medicare Costs For Johnson & Johnson’s Psoriasis Drug Stelara Double When Obtained at Pharmacies – Johnson & Johnson (NYSE:JNJ)
Medicare and its beneficiaries are paying significantly more for Stelara, Johnson & Johnson’s JNJ popular biologic drug used to treat…